Back to Journals » OncoTargets and Therapy » Volume 8

RETRACTED ARTICLE: Positive feedback between oncogenic KRAS and HIF-1α confers drug resistance in colorectal cancer

Authors Wang Y, Lei F, Rong W, Zeng Q, Sun W

Received 30 December 2014

Accepted for publication 1 April 2015

Published 26 May 2015 Volume 2015:8 Pages 1229—1237

DOI https://doi.org/10.2147/OTT.S80017

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 10

Editor who approved publication: Dr Faris Farassati



This article has been retracted

Read the retraction statement published online on 01/02/2026

This paper has been retracted.

Wang Y, Lei F, Rong W, Zeng Q, Sun W. Onco Targets Ther. 2015;8:1229–1237. https://doi.org/10.2147/OTT.S80017

We, the Editors and Publisher of the Journal OncoTargets and Therapy, have retracted the published article.

After publication, concerns have been raised by a third party about the integrity of the data in Figure 1 and 2 of the article.

Further investigation conducted by the Journal and Publisher confirmed unexpected similarities present in the Western blots representative of different samples and treatment conditions shown in Figures 1 and 2.

When approached for an explanation, the authors checked their data and confirmed there are fundamental errors present. Therefore, they have agreed to the retraction of this article and apologize for this oversight. The corresponding author listed in this publication has been informed.

As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Creative Commons License © 2015 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.